Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 137.20
Bid: 136.80
Ask: 137.60
Change: 0.60 (0.44%)
Spread: 0.80 (0.585%)
Open: 141.80
High: 141.80
Low: 135.40
Prev. Close: 136.60
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Third Quarter Trading Update

31 Oct 2023 07:00

RNS Number : 7710R
Elementis PLC
31 October 2023
 

 

31 October 2023

 

 

 

Elementis plc

Third Quarter Trading Update

 

Outlook unchanged, delivering resilient performance in line with expectations.

Elementis plc ("Elementis" or the "Group"), a global specialty chemicals company, today issues its scheduled trading update for the three months ended 30 September 2023 ("the quarter").

 

Third quarter business performance

The Group delivered a resilient performance as expected, in continued challenging market conditions, with Q3 revenue at a similar level to that seen in the first and second quarters. Against the prior year period, revenue was down 5% (down 7% on a constant currency basis), with lower revenues across both business segments. We remain focused on self-help actions including new business opportunities, price management and cost discipline.

 

Personal Care sales in the quarter were sequentially stable, but below a strong prior year period. We saw continued strong growth in Asia.

Performance Specialties delivered resilient performance as continued market related volume weakness across both Coatings and Talc was partially offset by pricing and mix benefits.

· Coatings sales were sequentially stable, though below the prior year period, with Asia showing modest improvement compared with the previous two quarters.

 

· Talc continued to benefit from self-help actions, with higher profit compared to the weak prior year period. We continue to focus on financial turnaround and pursuing new business opportunities.

 

Outlook

The Group is well positioned to deliver full-year financial performance in line with expectations, despite continuing weakness in underlying macro-economic conditions. Leverage reduction remains on track supported by continued inventory improvement in Q3.

 

Paul Waterman, CEO of Elementis, said:

"Elementis delivered a resilient third quarter performance, as we continued to focus on product innovation and customer relationships, while maintaining strong cost discipline. Despite the industry and macroeconomic conditions remaining uncertain, we remain well positioned to take advantage of growth opportunities across our market segments.

Following the sale of Chromium earlier this year, Elementis is now a focused specialty chemicals business. We look forward to providing detail about our go forward strategy at the upcoming Capital Markets Day."

 

Capital Markets Day

Elementis is hosting a Capital Markets Day on 14th November, at WPP, Sea Containers House, London, starting at 2.00 pm GMT.

Webcast will be available for those unable to attend. Registration for physical and virtual attendance is required, and can be accessed via the link Viewing "Elementis Capital Markets Day " (investis-live.com).

 

Enquiries

Investors: Eva Hatfield, Elementis plc Tel: +44 7553 340380

Press: Martin Robinson/Olivia Peters, Teneo Tel: +44 (0) 20 7353 4200

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTNKKBBFBDDOKN
Date   Source Headline
12th Apr 202411:33 amRNSDirector/PDMR Shareholding
12th Apr 202411:28 amRNSDirector/PDMR Shareholding
9th Apr 20246:04 pmRNSDirector/PDMR Shareholding
26th Mar 20244:07 pmRNSAnnual Financial Report & Notice of AGM
19th Mar 20243:02 pmRNSAdditional Listing
15th Mar 20241:00 pmRNSDirectorate Change
12th Mar 20244:38 pmRNSDirector/PDMR Shareholding
12th Mar 20244:33 pmRNSDirector/PDMR Shareholding
8th Mar 20245:56 pmRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSDirectorate changes
7th Mar 20247:00 amRNSPreliminary results year ended 31 December 2023
1st Mar 20249:30 amRNSBlock listing Interim Review
18th Jan 20247:00 amRNSTrading Update
2nd Jan 20249:45 amRNSTotal Voting Rights
1st Dec 202310:46 amRNSTotal Voting Rights
30th Nov 20239:38 amRNSDirector/PDMR Shareholding
14th Nov 20237:00 amRNS2023 Capital Markets Day
1st Nov 20239:46 amRNSTotal Voting Rights
31st Oct 20237:00 amRNSThird Quarter Trading Update
2nd Oct 20239:34 amRNSTotal Voting Rights
20th Sep 202312:09 pmRNSResponse to open letter from Franklin Templeton
12th Sep 20233:13 pmRNSDirector Declaration
8th Sep 20239:30 amRNSHolding(s) in Company
1st Sep 20239:49 amRNSBlock listing Interim Review
1st Sep 20239:42 amRNSTotal Voting Rights
1st Aug 20239:44 amRNSTotal Voting Rights
27th Jul 20232:16 pmRNSHolding(s) in Company
27th Jul 20237:00 amRNSHalf-year Report
20th Jul 202312:58 pmRNSHolding(s) in Company
3rd Jul 202310:21 amRNSTotal Voting Rights
29th Jun 20234:29 pmRNSDirector/PDMR Shareholding
23rd Jun 20239:32 amRNSDirector/PDMR Shareholding
30th May 20238:06 amRNSDirector Declaration
2nd May 20239:37 amRNSTotal Voting Rights
26th Apr 20232:12 pmRNSResult of AGM
26th Apr 20237:00 amRNSAGM Trading Statement
17th Apr 202310:15 amRNSDirector/PDMR Shareholding
17th Apr 202310:10 amRNSDirector/PDMR Shareholding
13th Apr 20234:24 pmRNSDirector/PDMR Shareholding
3rd Apr 202311:28 amRNSDirector Declaration
3rd Apr 20239:34 amRNSTotal Voting Rights
24th Mar 20239:27 amRNSDirector/PDMR Shareholding
22nd Mar 20234:02 pmRNSAnnual Financial Report & Notice of AGM
17th Mar 20232:58 pmRNSAdditional Listing
14th Mar 20237:30 amRNSDirector Declaration
9th Mar 20232:50 pmRNSDirector/PDMR Shareholding
9th Mar 20232:47 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSPreliminary results year ended 31 December 2022
1st Mar 20239:53 amRNSBlock listing Interim Review
1st Mar 20239:39 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.